In this research service, Frost & Sullivan provides qualitative and quantitative analyses of nutritional lipid ingredients such as omega-3 fatty acids, medium chain triglycerides (MCT), omega-6 (arachidonic acid or ARA) fatty acids, and phytosterols. We expect rising awareness of preventive healthcare approaches to avoid excessive healthcare expenditure on cardiovascular and other chronic diseases to drive the demand for nutritional lipids during the forecast period (2023–2030).

The study also provides qualitative and quantitative analysis of regional markets, including North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East and Africa (MEA). North America dominated the demand for nutritional lipids in 2022 due to high obesity cases in the region, resulting in the prevalence of cardiovascular diseases and growing consumer awareness of preventive healthcare approaches. Frost & Sullivan expects APAC to show the fastest growth during the forecast period due to the increasing middle-class population, per-capita disposable incomes, and consumer awareness about health and fitness.

We also considered the impact of the COVID-19 pandemic and other geopolitical situations, such as the Russia-Ukraine war, in the analysis.


Changing consumer preferences drive innovations in delivery formats of nutritional lipid supplements. The study provides the following qualitative insights into finished dosage formats for different nutritional lipids:
  • Overview of finished dosage formats for each nutritional lipid ingredient category
  • Drivers and pain points of formulators and consumers when choosing different dosage formats [softgel vs. liquid-filled capsules (LFCs) vs. gummies]
  • Competitive landscape highlighting finished dosage formulators offering LFCs and/or gummies
  • Technology landscape, focusing on novel dosage formats and delivery technologies